Evaluating Persistent Air Leaks with Thopaz+ System

This clinical trial investigates the use of the Thopaz+ digital drainage system to evaluate persistent air leaks (PALs) in adult patients who have undergone lung resection or have non-lung resection-related PALs. The study aims to provide a more accurate and objective method for identifying and managing air leaks compared to traditional techniques.

Persistent air leaks are a common complication after lung surgery or due to other lung conditions. They occur when air escapes from the lung into the chest cavity, often requiring prolonged chest tube drainage. Current methods for locating and treating these leaks rely on visual assessment during bronchoscopy, which can be subjective. The Thopaz+ system offers continuous, quantitative measurement of air leak volume, potentially improving the precision of diagnosis and treatment.

The trial will enroll 20 hospitalized adults with PALs lasting at least five days despite chest tube drainage. Participants will undergo standard bronchoscopy for PAL management, during which the Thopaz+ system will be used to measure air leak volumes. Researchers will compare data from the Thopaz+ with results from the traditional balloon occlusion test to determine if the digital system provides additional valuable information.

Primary outcomes focus on the feasibility of obtaining continuous air leak measurements during the procedure. Secondary outcomes include identifying specific airways responsible for leaks, measuring changes in leak severity, and tracking treatment success based on both clinical assessments and quantitative data from the Thopaz+ system.

This research is significant because improved methods for managing PALs could reduce hospital stays, decrease the need for additional interventions, and improve patient recovery. The study may demonstrate how digital monitoring systems can enhance standard clinical practices in pulmonary care.

For patients and caregivers, this trial represents progress toward more precise and potentially more effective treatments for persistent air leaks. The non-invasive nature of the Thopaz+ monitoring means participants won't experience additional procedures beyond their standard care. Results could lead to wider adoption of digital drainage systems in managing postoperative complications.

The importance of this research extends beyond the immediate study population. Persistent air leaks represent a significant healthcare burden, often leading to extended hospitalizations and increased costs. By exploring innovative approaches to this common problem, the study contributes to broader efforts to improve outcomes in thoracic medicine. The integration of digital technology with traditional clinical methods exemplifies how modern medicine continues to evolve, offering hope for better solutions to challenging medical conditions.